Last reviewed · How we verify
Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Amidate | Etomidate | Pfizer Inc. | General Anesthetic [EPC] | GABA A receptor alpha-2/beta-2/gamma-2 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer Inc. · 1 drug in Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization:
- Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization treatment updates — RSS
- Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization treatment updates — Atom
- Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization treatment updates — JSON
Cite this brief
Drug Landscape (2026). Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/supplementation-of-nitrous-oxide-in-oxygen-during-maintenance-of-anesthesia-for-cervical-conization. Accessed 2026-06-10.
Related
- Supplementation of nitrous oxide in oxygen during maintenance of anesthesia for cervical conization full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing